Drugs / SR123781A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00338897 | May 2006 → May 2007 | venous thromboembolism | Sanofi | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SR123781A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00338897 ↗ |
| Action | Inhibit | “a synthetic oligosaccharide with a mixed profile of anti-factor Xa and IIa activities” PMID 18402906 ↗ Apr 2008 |
| Modality | Oligonucleotide (other) | “SR123781A, a synthetic oligosaccharide with a mixed profile of anti-factor Xa and IIa activities” PMID 18402906 ↗ Apr 2008 |
| Route | Subcutaneous | “Dose Ranging Study of Subcutaneous SR123781A With an Enoxaparin Calibrator Arm” NCT00338897 ↗ |